Eli Lilly is developing orforglipron , a small-molecule oral GLP-1 agonist, but this is a different compound, not oral tirzepatide
Bottom line: Combining naltrexone and semaglutide may provide a synergistic effect that helps reduce food noise and enhance weight loss, but it must be initiated and monitored by a healthcare provider to ensure safety
Fabrini R, Bocedi A, Del Grosso E, Morici L, Federici G, Palleschi A et al
RD-MI: Retrieved Drop-outs Multiple Imputation 2 Not included in the pre-specified hierarchical testing
Additionally, some are eligible for insurance coverage, while others require paying fully out of pocket